Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04282850 · ClinicalTrials.gov registry record · NA
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF
A NA study of Atrial Fibrillation and Heart Failure With Normal Ejection Fraction, sponsored by Inova Health Care Services.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04282850 is a NA study of Atrial Fibrillation and Heart Failure With Normal Ejection Fraction that is active but no longer recruiting, run by Inova Health Care Services. The registered enrollment target is 60 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04282850, a NA study of Atrial Fibrillation and Heart Failure With Normal Ejection Fraction, is active but no longer recruiting, sponsored by Inova Health Care Services.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective non-blinded randomized control pilot study comparing the effect of pulmonary vein isolation against medical management of atrial fibrillation in patients with Heart Failure with preserved Ejection Fraction (HFpEF).
Conditions Studied
Interventions
- PROCEDURE Pulmonary Vein Isolation
Study Locations (1)
Virginia
- Inova Heart and Vascular Institute - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-07-10 |
| Est. Completion | 2026-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04282850
The ClinicalTrials.gov registry entry for NCT04282850 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Pulmonary Vein Isolation is the first listed.
NCT04282850 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT04282850 about?
NCT04282850 is a clinical study titled "Ablation Versus Medical Management of Atrial Fibrillation in HFpEF". This is a prospective non-blinded randomized control pilot study comparing the effect of pulmonary vein isolation against medical management of atrial fibrillation in patients with Heart Failure with preserved Ejection Fraction (HFpEF).
What is the current status of trial NCT04282850?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-07-10. Estimated completion is 2026-02.
What conditions does trial NCT04282850 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Heart Failure With Normal Ejection Fraction.
What interventions are being tested in trial NCT04282850?
The interventions under investigation include: Pulmonary Vein Isolation (PROCEDURE).
Who is sponsoring clinical trial NCT04282850?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04282850 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Explore more on PlainTrial
Atrial Fibrillation
All registered trials for this condition
Heart Failure With Normal Ejection Fraction
All registered trials for this condition
Virginia
All trials with a study site in Virginia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.